Establishment of a retinoic acid-resistant human acute promyelocytic leukaemia (APL) model in human granulocyte-macrophage colony-stimulating factor (hGM-CSF) transgenic severe combined immunodeficiency (SCID) mice
1998

Creating a Mouse Model for Retinoic Acid-Resistant Acute Promyelocytic Leukaemia

Sample size: 4 publication Evidence: moderate

Author Information

Author(s): Y Fukuchi, M Kizaki, K Kinjo, N Awaya, A Muto, M Ito, Y Kawai, A Umezawa, J Hata, Y Ueyama, Y Ikeda

Primary Institution: Keio University School of Medicine

Hypothesis

Can a human retinoic acid-resistant APL model be established in SCID mice?

Conclusion

The study successfully established the first human retinoic acid-resistant APL model in SCID mice, which can be used for further research on APL and potential therapies.

Supporting Evidence

  • UF-1 cells formed tumors in all hGMTg SCID mice but not in control mice.
  • Single-cell suspensions from tumors showed similar features to parental UF-1 cells.
  • All-trans retinoic acid did not change the growth or differentiation of UF-1 cells.

Takeaway

Researchers made a special type of mouse that can help us understand a kind of blood cancer that doesn't respond to a common treatment.

Methodology

The study involved transplanting a retinoic acid-resistant APL cell line into transgenic SCID mice and assessing tumor formation and characteristics.

Limitations

The model may not fully replicate human APL conditions due to the differences between species.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication